Personalized Medicine

Symposium
on
Personalized Medicine
Organized by
the German Academy of Sciences Leopoldina
and the Austrian Academy of Sciences
January 12 – 14, 2012
Festive Hall of the
Austrian Academy of Sciences
Dr. Ignaz Seipel-Platz 2
1010 Vienna
Itinerary
Thursday, JanUARY 12
19.00
Opening ceremony & welcome addresses
Keynote lecture
Peter Sloterdijk | Professor of Philosophy and Aesthetics, Rector, University of Art and Design Karlsruhe, Germany
Friday, JanUARY 13
09.00–09.30
Opening remarks
09.30–10.00
Setting the stage
Philipp U. Heitz | Prof. emeritus, Dpt. of Pathology, University of Zurich, Switzerland
Individualized medicine: Status quo
10.00–10.30
Jouni Uitto | Professor and Chairman, Dpt. of Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA, USA
Predicting disease: Prenatal and presymptomatic testing and preimplantation genetic diagnosis of heritable skin
diseases
10.30–11.00
Giuseppe Pantaleo | Professor of Medicine, Chief, Division of Immunology and Allergy, Head, Laboratory of AIDS
Immunopathogenesis, Department of Medicine, Centre Hospitalier Universitaire Vaudois (CHUV),
University of Lausanne, Switzerland
Individualized antiviral therapy: Lessons from HIV infection
11.00–11.30
Coffee break
11.30–12.00
Boris C. Bastian | Professor of Cancer Biology, University of California, San Francisco, CA, USA
Melanoma – Distinct biologic subtypes and their impact on therapy and disease classification
12.00–12.30
Reinhard Dummer | Vice Chairman, Dpt. of Dermatology, University of Zurich, Switzerland
Tailoring skin cancer therapy
12.30–13.00
Thomas S. Kupper | Chairman, Dpt. of Dermatology, Brigham and Women’s Hospital, Harvard Medical School,
Boston, MA, USA
Molecular and cellular heterogeneity of CTCL – Therapeutic and prognostic relevance
13.00–14.00
Lunch break
Itinerary
Value of population-based data for individual patient care
14.00–14.30
Matthias Schmuth | Chairman, Dpt. of Dermatology, Medical University of Innsbruck, Austria
Presence and absence of filaggrin mutations – Mechanisms, prognostic and therapeutic relevance
14.30–15.00
Richard A. Flavell | Chairman, Dpt. of Immunobiology, Yale School of Medicine, New Haven, CT, USA
Personalized medicine – the impact of the environment
15.00–15.30
Günter Stock | President of the Academy of Sciences Berlin-Brandenburg, Berlin, Germany
Pharmaceutical industry between block buster and individually adapted therapy
15.30–16.00
Coffee break
16.00–16.30
Erwin Böttinger | Director of the Charles R. Bronfman Institute for Personalized Medicine,
Irene and Dr. Arthur Fishberg Chair and Professor in Medicine, and Professor of Pharmacology and
Systems Therapeutics, Mount Sinai School of Medicine, NYC, NY, USA
Creating an evidence-base for personalized medicine in clinical care: Need for clinical implementation research
16.30–17.00
Markus Müller | Chairman, Dpt. of Clinical Pharmacology, Medical University of Vienna, Austria
Study design in the era of personalized medicine
17.00–17.30
Giulio Superti-Furga | Scientific Director, CeMM – Research Center for Molecular Medicine of the
Austrian Academy of Sciences, Vienna, Austria
-omics: Hopefully not Comics!
17.30–18.00
Matthias Schwab | Chairman, Dpt. of Clinical Pharmacology, Dr. Margarete Fischer-Bosch Institute,
Eberhard-Karl University, Tübingen, Germany
Pharmacogenomics: Perspectives and future directions
Saturday, JanUARY 14
09.00–09.30
Kurt Zatloukal | Vice Chairman, Institute of Pathology, Medical University of Graz, Austria
Biobanks: Key infrastructure for personalized medicine
09.30–10.00
Hans-Werner Mewes | Professor and Chairman, Department of Genome Oriented Bioinformatics, Technical University
of Munich, and Director of the Institute of Bioinformatics and Systems Biology at the Helmholtz Center Munich, Germany
Systems biology from correlation to causation for personalized medicine
Itinerary
10.00–10.30
Gregory Lanza | Professor of Medicine, Biomedical Engineering and Biology and Biomedical Sciences,
Washington University School of Medicine, St. Louis, MO, USA
The perfect individual image
10.30–11.00
Coffee break
Individualized medicine – a risk for freedom and privacy?
11.00–11.30
Irmgard Griss | President of the Austrian Supreme Court of Justice, Vienna, Austria
Legal problems
11.30–12.00
Annette Widmann-Mauz | Parliamentary State Secretary, Federal Ministry of Health, Berlin, Germany
Political and regulatory aspects of personalized medicine
12.00–12.30
Erich W. Streissler | Prof. emeritus, Dpt. of Economy, University of Vienna, Austria
Who is going to pay?
12.30–13.30
Lunch break
13.30–14.00
Christine Patch | Consultant Genetic Counsellor Guys and St. Thomas‘ NHS Foundation Trust
Reader in Clinical Genetics Kings College London, London, UK
Points of control for genomic tests: Regulation is not the only answer
14.00–14.30
Matthias Beck | Institute for Moral Theology, University of Vienna, Austria
Anthropological and ethical questions in the context of genetics and epigenetics
14.30–15.00
Martin Röcken | Chairman, Dpt. of Dermatology, Eberhard-Karl University, Tübingen, Germany
Georg Stingl | Chairman, Div. of Immunology, Allergy and Infectious Diseases, Dpt. of Dermatology,
Medical University of Vienna, Austria
Perfect health: Fiction, hope or danger?
15.00–15.30
General discussion
15.30-15.45
Closing remarks Organizers:
Georg Stingl, M.D., ML, w.M. OeAW
Martin Röcken, M.D., ML
Local organization team:
Patrick M. Brunner, M.D. | Heike Heidemann
Austrian Academy of Sciences, Dr. Ignaz Seipel-Platz 2, 1010 Vienna, Austria
For further information please contact:
[email protected]
www.oeaw.ac.at/persmed2012/